Ryan SpecialtyRYAN

The company reported revenue of about $917 million for the quarter, which was higher than the $870 million analysts expected. Profits were also stronger than anticipated, with adjusted earnings of $0.74 per share beating the $0.60 estimate. Organic revenue growth, which measures sales from existing businesses rather than new acquisitions, was about 7 percent.

Management used its cash to reward owners, spending $260 million to buy back its own shares and paying out $24 million in dividends. This performance shows the business is successfully navigating a complex insurance market where its expertise in hard-to-place risks remains in high demand.

See the full quarter, and how our tracked metrics did

Source: 8-K filing

Key highlights

• Strong earnings per share growth: Adjusted earnings grew 12.1% to $0.74 per share, showing that the company can increase its bottom line faster than its sales. This growth comes as the company manages its mix of specialty insurance products even while total operating expenses rose 10.9% to $736.3 million.
• Organic revenue growth slowed: Organic revenue growth, which excludes the impact of buying other companies, was 6.7% compared to 7.1% a year ago. This is the first time in several quarters that this key measure of internal health has dipped below the company's 10% annual long-term target.
• Underwriting management leads growth: The underwriting management division grew 12.8% to $303.8 million, far outpacing the 4.5% growth in the larger wholesale brokerage business. This shift is meaningful because underwriting management now makes up 33.6% of total commissions, up from 32.1% last year.
• Massive capital return: The company returned $284.5 million to shareholders this quarter, with $260.0 million of that used to buy back 8.1 million shares. These buybacks reduce the total number of shares and can help boost the value of the remaining shares for long-term owners.
• Full year outlook maintained: Management expects organic revenue growth to stay in the mid-single digits for all of 2026. They also warned that a key profit measure, adjusted EBITDAC margin, will likely fall by 0.5% to 1.0% compared to last year as they continue to invest in the business.

Our take: This was a soft quarter for Ryan Specialty as organic growth slowed to 6.7%, missing the double-digit pace we look for in this business. While the profit per share beat expectations, the rising expenses and the forecast for tighter margins through the rest of the year suggest the company is facing a tougher climb to reach its long-term goals.